Amended and Restated Investors' Rights Agreement



 Exhibit 4.3 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), dated as of this
13th day of April, 2010, by and among Cancer Genetics,
Inc., a Delaware corporation (the “Company”), the individuals or entities listed on Schedule I hereto (the “Series A Preferred Stockholders”), and the individuals or entities listed on Schedule II hereto (the “Series B
Preferred Stockholders”). The Company, the Series A Preferred Stockholders and the Series B Preferred Stockholders are sometimes referred to herein individually, as a “Party” and collectively, as the “Parties.” 

WITNESSETH: 
 WHEREAS, the Company and certain individuals and/or entities have entered into Series B Convertible Preferred Stock Purchase Agreements pursuant to which the Company has agreed to issue to such
purchasers, and such purchasers have agreed to purchase from the Company, shares of Series B Preferred Stock of the Company (the “Series B Preferred Stock”); 
 WHEREAS, the Company and the holders of the issued and outstanding shares of Series A Preferred Stock are parties to a certain investors’ right agreement, dated September 11, 2007 (the
“Investors’ Rights Agreement”); 
 WHEREAS, the Company and the holders of at least a majority of the
issued and outstanding shares of Series A Preferred Stock desire to amend and restate the Investors’ Rights Agreement; and 

WHEREAS, in consideration of the Series B Preferred Stockholders entering into the Series B Convertible Preferred Stock Purchase
Agreement, of even date herewith (the “Purchase Agreement”), the Company has agreed to provide the registration rights, purchase rights, information rights and other rights set forth in this Agreement to the Series B Preferred
Stockholders. 
 NOW, THEREFORE, in consideration of the premises and covenants hereafter contained, the Parties,
intending to be legally bound, hereby agree as follows: 
 1. Covenants and Agreements. 

The Company covenants and agrees with the Series A Preferred Stockholders and the Series B Preferred Stockholders, as follows:

 1.1 Periodic Reports and Other Information. The Company shall furnish to each holder of Series A Preferred Stock and
Series B Preferred Stock of the Company (“Series A Preferred Stock” and “Series B Preferred Stock” respectively), within sixty (60) days after the end of each calendar quarter, an unaudited balance sheet and statements of
income and accumulated deficit, statement of cash flow, schedule of operating expenses and notes to financial statements as of the end of such quarter and for the current fiscal year to the end of such quarter setting forth in comparative form, the
Company’s financial statements for the corresponding periods for the prior fiscal year. 
 1.2 Annual Financial
Statements. The Company shall furnish to each holder of Series A Preferred Stock and Series B Preferred Stock, within ninety (90) days after the end of each fiscal year, an unaudited balance sheet and statements of income and accumulated
deficit, statement of cash flow, schedule of operating expenses and notes to financial statements of the Company for such year. 

1.3 Availability of Rule 144 and Rule 144A. At such time as the Company becomes subject to the reporting requirements of
Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), whether as a result of the Company’s initial public offering or any other public offering of the Company’s capital stock, or because the
Company meets the criteria of Section 12 of the Exchange Act, it shall file with the Securities and Exchange Commission (the “Commission”) all reports required to be filed by it pursuant to Section








 
13 or Section 15(d) of the Exchange Act and applicable rules and regulations thereunder, and shall maintain full compliance with the current public information requirements of Rule 144 and
Rule 144A promulgated under the Securities Act, or any similar successor to such rule. 
 1.4 Inspection. The Company
shall permit the holders of Series A Preferred Stock and Series B Preferred Stock and any authorized representative thereof, to visit and inspect the properties of the Company, including its corporate and financial records, to examine its records
and make copies thereof and to discuss its affairs, finances and accounts with its officers, at all such reasonable times and upon reasonable notice, up to two (2) times per year. The holders of Series A Preferred Stock and Series B Preferred
Stock and their agents and representatives, agree to maintain the confidentiality of all financial and other confidential information of the Company acquired by them. If requested by the Company, the holders of Series A Preferred Stock and Series B
Preferred Stock and each of their participating representatives shall execute a confidentiality agreement with the Company in such reasonable form and substance as the Company shall specify. 

1.5 Books and Records. The Company shall keep adequate records and books of account with respect to its business activities in
which proper entries reflecting all of its financial transactions are maintained. 
 1.6 Maintenance of Existence and Conduct
of Business. The Company shall do, or cause to be done, all things reasonably necessary to preserve and keep in full force and effect its corporate existence, and its rights and franchises. 

2. Registration Rights. 
 2.1 Certain Definitions. As used in this Section 2, the following terms shall have the following respective meanings: 
 (a) “Business Day” shall mean any day that is not a Saturday, a Sunday or a day on which banks are required or permitted to be closed in the State of New York. 

(b) “Commission” shall mean the Securities and Exchange Commission, or any other federal agency at the time administering the
Securities Act. 
 (c) “Conversion Shares” shall mean shares of Common Stock issued or issuable upon conversion of
the Series A Preferred Stock and Series B Preferred Stock. 
 (d) “Exchange Act” shall mean the Securities Exchange
Act of 1934, as amended, or any similar federal statute, and the rules and regulations of the Commission issued under such Act, as they each may, from time to time, be in effect. 

(e) “Holder” for the purpose of this Section 2 shall mean each holder of Series A Preferred Stock, and Series B Preferred
Stock including any person to whom the rights granted under this Section 2 are transferred pursuant to Section 2.2 hereof. 
 (f) “Initial Public Offering” shall mean the initial underwritten sale of equity securities by the Company pursuant to an effective registration statement under the Securities Act. 

(g) “Registrable Shares” shall mean (a) the Conversion Shares, and (b) all other shares of Common Stock now owned or
hereafter acquired by the Purchaser or any of their respective affiliates including by conversion or exercise of other securities held by a holder of Series A Preferred Stock, Series B Preferred Stock or Conversion Shares, but excluding in each case
shares of Common Stock and Conversion Shares which have been (i) registered under the Securities Act pursuant to an effective registration statement filed thereunder and disposed of in accordance with the registration statement covering them,
or (ii) publicly sold pursuant to Rule 144 or Rule 701 under the Securities Act. 
 (h) “Registration Statement”
shall mean a registration statement filed by the 







 
Company with the Commission for a public offering and sale of securities of the Company (other than a registration statement on Form S-8 or Form S-4, or their successors, or any other form for a
limited purpose, or any registration statement covering only securities proposed to be issued in exchange for securities or assets of another corporation). 
 (i) “Securities Act” shall mean the Securities Act or any similar federal statute, and the rules and regulations of the Commission issued under the Securities Act, as they each may, from time to
time, be in effect. 
 2.2 Assignment of Registration Rights. The rights to cause the Company to register Registrable
Shares pursuant to this Section 2 may be assigned (but only with all related obligations) by a Holder; provided, however, that the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address
of such transferee and the securities with respect to which such registration rights are being assigned. 
 2.3 Incidental
Registration. 
 (a) Opportunity to Participate. Whenever the Company proposes to file a Registration Statement
(other than by a registration on Form S-4 or Form S-8, any successor forms, or any form not available for registering shares for sale to the public pursuant to a public offering or pursuant to registrations in which the only stock being registered
is Common Stock issuable upon conversion of debt securities which are also being registered) at any time and from time to time, it will, prior to such filing, give written notice to all Holders of its intention to do so and, upon the written request
of a Holder or Holders given within thirty (30) days after the Company provides such notice, the Company shall use reasonable commercial efforts to cause all Registrable Shares owned by such Holders which the Company has been requested by such
Holder or Holders to register to be registered under the Securities Act; provided that the Company shall have the right to postpone or withdraw any registration effected pursuant to this Section 2.3 without obligation to any Holder. 

(b) Demand Registration. The Holders of a majority of then outstanding shares of Series B Preferred Stock shall be entitled to require
that the Company register for their resale under the Securities Act the shares of Common Stock underlying the Series B Preferred Stock. Such demand shall be exercisable by delivery of written notice by the Holders of the majority of outstanding
Series B Preferred Stock to the Company. The Holders may deliver such written notice at any time; provided, however, the obligation of the Company to file a Registration Statement shall not accrue until a date which is 90 days after the completion
of the Company’s completion of a merger with a public shell company under which the public company merges with the Company or acquires (the “Acquisition”) all of the outstanding securities of the Company in exchange for issuance of
securities of Public Company. Upon receipt of any such demand notice, the Company shall use reasonable efforts to file the registration statement as promptly as possible, but in no event more than 60 days after receipt of such demand (subject to the
completion of the Acquisition as stated above), and shall use its reasonable efforts to have such Registration Statement declared effective by the SEC as promptly as possible. 

(c) Terms; Exclusions. In connection with any offering under this Section 2.3 involving an underwriting, the Company shall
not be required to include any Registrable Shares in such underwriting unless the Holders thereof accept the terms of the underwriting as agreed upon between the Company and the underwriter selected by the Company), and then only in such quantity as
will not, in the opinion of the underwriters, adversely affect the offering by the Company. If in the opinion of the managing underwriter the registration of all, or part of, the Registrable Shares which the Holders have requested to be included
would adversely affect such public offering, then the Company shall be required to include in the underwriting only that number of Registrable Shares, if any, which the managing underwriter believes may be sold without causing such adverse effect;
provided, however, that the number of Registrable Shares included in such underwriting shall not be reduced unless all other securities of any other stockholder electing to participate in the offering are first excluded from the underwriting and
offering. If the number of Registrable Shares to be included in the underwriting in accordance with the foregoing is less than the total number of shares which the Holders of Registrable Shares have requested to be included, then the Company may
include all securities proposed to be registered by the Company to be sold for its own account and the Holders of Registrable Shares who have requested registration shall participate in the underwriting pro rata based upon their total ownership of
shares of Common Stock of the Company requested to be registered, together with any additional stockholders, if any, requesting registration. If any Holder would thus 







 
be entitled to include more shares than such Holder requested to be registered, the excess shall be allocated among other requesting Holders pro rata based upon their total ownership of
Registrable Shares. 
 (d) Underwriting Agreement. All Holders of Registrable Shares proposing to distribute their
securities in an offering under this Section 2.3 involving an underwriting shall (together with the Company and other shareholders, if any, of securities distributing their shares through such underwriting) enter into an underwriting agreement
in customary form with the underwriter or underwriters selected for the underwriting. 
 2.4 Registration Procedures. If
and whenever the Company is required by the provisions of this Agreement to use commercially reasonable efforts to effect the registration of any of the Registrable Shares under the Securities Act, the Company shall: 

(a) prepare and file with the Commission a Registration Statement with respect to such Registrable Shares and use commercially
reasonable efforts to cause that Registration Statement to become and remain effective for the period of the distribution contemplated thereby (determined as hereinafter provided); 

(b) prepare and file with the Commission any amendments and supplements to the Registration Statement and the prospectus in connection
therewith as may be necessary to keep the Registration Statement effective until the earliest of (i) the period of time required by the Commission, (ii) one hundred eighty (180) days from the effective date, or (iii) the sale of all
Registrable Shares covered thereby; provided, that the Company may discontinue any registration of its securities that are not Registrable Shares (and, under the circumstances specified in Section 2.3(b), its securities that are Registrable
Shares) at any time prior to the effective date of such Registration Statement; 
 (c) furnish to each selling Holder such
reasonable number of copies of the prospectus, including each preliminary prospectus, in conformity with the requirements of the Securities Act, and such other documents as the selling Holder may reasonably request in order to facilitate the public
sale or other disposition of the Registrable Shares owned by the selling Holder; 
 (d) use commercially reasonable efforts to
register or qualify the Registrable Shares covered by the Registration Statement under the securities or blue sky laws of such states as the selling Holders shall reasonably request, and do any and all other acts that may be necessary or desirable
to enable the selling Holders to consummate the public sale or other disposition in such states of the Registrable Shares owned by the selling Holder; provided, however, that the Company shall not be required in connection with this
Section 2.4(d) to qualify as a foreign corporation or execute a general consent to service of process in any jurisdiction; 
 (e) notify each Holder of Registrable Shares covered by the registration statement at any time when a prospectus relating thereto is required to be delivered under the Securities Act of the happening of
any event of which the Company has knowledge as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated
therein or necessary to make the statements therein not misleading in the light of the circumstances then existing. Each Holder of Registrable Shares agrees upon receipt of such notice forthwith to cease making offers and sales of Registrable Shares
pursuant to such Registration Statement or deliveries of the prospectus contained therein for any purpose until the Company has prepared and furnished such amendment or supplement to the prospectus as may be necessary so that, as thereafter
delivered to purchasers of such Registrable Shares, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in
the light of the circumstances then existing; 
 (f) if the offering is underwritten and at the request of any Holders of
Registrable Shares, use commercially reasonable efforts to furnish on the date that Registrable Shares are delivered to the underwriters for sale pursuant to such registration: 

(i) an opinion dated such date of counsel representing the Company for the purposes of such registration, addressed to the underwriters
and to such Holder, stating that such Registration Statement has become effective under the Securities Act and that (A) to the best knowledge of such counsel, no stop order suspending the effectiveness thereof has been issued and no proceedings
for that purpose have been instituted 







 
or are pending or contemplated under the Securities Act, (B) the Registration Statement, the related prospectus and each amendment or supplement thereof comply as to form in all material
respects with the requirements of the Securities Act (except that such counsel need not express any opinion as to financial statements and the notes thereto and the schedules and other financial and statistical data contained therein) and
(C) to such other effect as reasonably may be requested by counsel for the underwriters or by such Holder or its counsel; and 
 (ii) a letter dated such date from the independent certified public accountants retained by the Company, addressed to the underwriters and to such Holder, stating that they are independent certified
public accountants within the meaning of the Securities Act and that, in the opinion of such accountants, the financial statements of the Company included in the Registration Statement or the prospectus, or any amendment or supplement thereof,
comply as to form in all material respects with the applicable accounting requirements of the Securities Act, and such letter shall additionally cover such other financial matters (including information as to the period ending no more than five
Business Days prior to the date of such letter) with respect to such registration as such underwriters reasonably may request; 

(g) make available for inspection upon reasonable notice during the Company’s regular business hours by each Holder of Registrable
Shares, any underwriter participating in any distribution pursuant to such registration statement, and any attorney, accountant or other agent retained by such Holder or underwriter, all financial and other records, pertinent corporate documents and
properties of the Company, and cause the Company’s officers, directors and employees to supply all information reasonably requested by and such Holder, underwriter, attorney, accountant or agent in connection with such Registration Statement;
and 
 (h) provide a CUSIP number for all Registrable Shares covered by such Registration Statement not later than the
effective date of such Registration Statement and, if applicable, provide the Company’s transfer agent with printed certificates for such Registrable Shares which are in a form eligible for deposit with the Depositary Trust Company. 

In connection with each registration hereunder, each Holder of Registrable Shares shall (a) provide such information and execute
such documents as may reasonably be required in connection with such registration, (b) agree to sell Registrable Shares on the basis provided in any underwriting arrangements, and (c) complete and execute all questionnaires, powers of
attorney, indemnities, underwriting agreements, and other documents required under the terms of such underwriting arrangements, which arrangements shall not be inconsistent herewith. 

In connection with each registration pursuant to Section 2.4 covering an underwritten public offering, the Company and each Holder
agree to enter into a written agreement with the managing underwriter selected in the manner herein provided in such form and containing such provisions as are customary in the securities business of such an arrangement between such underwriter and
companies of the Company’s size and investment stature. 
 2.5 Allocation of Expenses. The Company will pay all
Registration Expenses (as hereinafter defined) incurred with any registration, filing or qualification of Registrable Shares under this Agreement. For purposes of this Section 2, the term “Registration Expenses” shall mean all
expenses incurred by the Company in complying with this Section 2, including without limitation, all registration and filing fees, exchange listing fees, printing expenses, the fees and disbursements of counsel for the Company and the
reasonable fees and disbursements of one counsel selected by the selling Holders (not to exceed an aggregate amount of $15,000 per registration), the fees and disbursements of the Company’s accountants, state blue sky fees and expenses, and the
expense of any special audits incident to or required by any such registration, but excluding underwriting discounts, transfer taxes, selling commissions and the fees and expenses of the selling Holders’ own counsel (other than the one counsel
selected to represent all of the selling Holders). 
 2.6 Indemnification. 

(a) In the event of registration of any of the Registrable Shares under the Securities Act pursuant to this Agreement, the Company will
defend, indemnify and hold harmless the seller of such Registrable Shares, each of its directors, officers or partners, each underwriter (if any) within the meaning of the 







 
Exchange Act (an “Underwriter”) of such Registrable Shares and each other person, if any, who controls such seller or Underwriter within the meaning of the Securities Act or the
Exchange Act (a “controlling person”) against any losses, claims, damages or liabilities, joint or several, to which such seller or Underwriter or controlling person may become subject under the Securities Act, the Exchange Act, blue sky
laws or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of any material fact contained in any Registration
Statement under which such Registrable Shares were registered under the Securities Act, any preliminary prospectus or final prospectus contained in the Registration Statement, or any amendment or supplement to such Registration Statement if such
statement was made by or on behalf of such seller of Registrable Shares, or (ii) the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
in which they were made, not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any federal securities or state blue sky law or any rule or regulation promulgated under the Securities
Act, the Exchange Act or any federal securities or blue sky law in connection with the offering covered by such Registration Statement; and the Company will reimburse such seller or Underwriter and each such controlling person for any legal or any
other expenses reasonably incurred by such seller or Underwriter or controlling person in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the Company will not be liable in any
such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any untrue statement or omission made in such Registration Statement, preliminary prospectus or prospectus, or any such amendment or supplement, in
reliance upon and in conformity with information furnished to the Company, in writing, by or on behalf of such seller, underwriter or controlling person specifically for use in the preparation thereof or if such misstatement or omission was
corrected in any amendment or supplement provided to a selling Holder pursuant to Section 2.4(b) and (c) and the selling Holder failed to deliver such amendment or supplement. 

(b) In the event of any registration of any of the Registrable Shares under the Securities Act pursuant to this Agreement, each seller
of Registrable Shares, severally and not jointly, will indemnify and hold harmless the Company, each of its directors and officers, each Underwriter (if any) and each controlling person, if any, of the Company or Underwriter against any losses,
claims, damages or liabilities, joint or several, to which the Company, such directors and officers, any Underwriter or controlling persons may become subject under the Securities Act, Exchange Act, blue sky laws or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement under which such Registrable
Shares were registered under the Securities Act, any preliminary prospectus or final prospectus contained in the Registration Statement, or any amendment or supplement to the Registration Statement if such statement was made by or on behalf of such
seller of Registrable Shares, or (ii) any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading, if
the statement, omission or violation was made or occurred in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of such seller of Registrable Shares, specifically for use in connection with the
preparation of such Registration Statement, prospectus, amendment or supplement or if such misstatement or omission was corrected in any amendment or supplement provided to such seller of Registrable Shares pursuant to Section 2.4(b) and
(c) and such seller of Registrable Shares failed to deliver such amendment or supplement, or (iii) any violation or alleged violation by such seller of Registrable Shares of the Securities Act, the Exchange Act, any federal securities or
blue sky law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any federal securities or blue sky law in connection with the offering covered by such registration statement and each seller of such Registrable Shares
will reimburse the Company and each such director, officer or underwriter and each such controlling person for any legal or any other expenses reasonably incurred by the Company, such director, officer or underwriter or such controlling person in
connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the obligations of each such seller of Registrable Shares hereunder shall be limited to an amount equal to the net proceeds
to each such seller of Registrable Shares of Registrable Shares sold as contemplated herein. 
 (c) Each Party entitled to
indemnification under this Section 2.6 (the “Indemnified Party”) shall give notice to the Party required to provide indemnification (the “Indemnifying Party”) promptly after such Indemnified Party has actual knowledge of any
claim as to which indemnity may be sought, and shall permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting therefrom; provided, however, that counsel for the Indemnifying Party, who shall conduct the
defense of such claim or litigation, shall be 







 
approved by the Indemnified Party (whose approval shall not be unreasonably withheld, conditioned or denied); and, provided, further, that the failure of any Indemnified Party to give notice as
provided herein shall not relieve the Indemnifying Party of its obligations under this Section 2.6 unless the failure to give such notice timely actually effects in a material manner the Indemnifying Party. The Indemnified Party may participate
in such defense at such party’s expense; provided, however, that the Indemnifying Party shall pay such expense if representation of such Indemnified Party by the counsel retained by the Indemnifying Party would be inappropriate due to actual or
potential differing interests between the Indemnified Party and any other party represented by such counsel in such proceeding. No Indemnifying Party, in the defense of any such claim or litigation shall, except with the consent of each Indemnified
Party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect of such claim
or litigation, and no further obligation to indemnify an Indemnified Party shall exist in connection with either of the following without the prior written consent of the Indemnifying Party, which consent shall not be unreasonably withheld:
(i) judgment entered with the consent of the Indemnified Person; or (ii) settlement of such claim or litigation. 

2.7 Information by Holder. 
 (a) Each Holder of Registrable Shares included in any registration shall furnish to the Company such information regarding such Holder and the distribution proposed by such Holder as the Company may
reasonably request in writing and as shall be required in connection with any registration, qualification or compliance referred to in this Section 2. 
 (b) Each Holder of Registrable Shares shall use reasonable efforts to report to the Company sales made pursuant to any registration of such Registrable Shares. 

2.8 “Market Stand-Off” Agreement. Each Holder, if requested by the Company and an underwriter of Common Stock or other
securities of the Company, shall agree not to sell or otherwise transfer or dispose of any Registrable Shares or other securities (other than shares of Common Stock being registered in such offering) of the Company held by such Holder for a
specified period of time (not to exceed one hundred eighty (180) days) following the effective date of a Registration Statement; provided, however, that such restriction shall apply only to the registration statement relating to the
Company’s Initial Public Offering, and shall not extend to any securities included in such Registration Statement; and provided further that all officers and directors of the Company shall agree to be bound by such restriction and the Company
shall use all reasonable efforts to obtain a similar covenant from each holder of at least one percent (1%) of the outstanding capital stock of the Company. Such agreement shall be in writing in a form satisfactory to the Company and such
underwriter. The Company may impose stop transfer instructions with respect to the Registrable Shares or other securities subject to the foregoing restriction until the end of the market stand-off period. 

3. Miscellaneous. 
 3.1 Termination. 
 (a) Rights granted under Section 1 herein will
terminate upon the closing of the Initial Public Offering (as hereinafter defined). For purposes of this Agreement, “Initial Public Offering” means the closing of an underwritten public offering pursuant to an effective registration
statement in connection with an initial public offering with gross proceeds of $25,000,000 or more, or consummation of a reverse merger of the Company with a public company that files reports with the SEC under the Securities Exchange Act of 1934.

 (b) Rights granted under Section 2 herein will terminate on the earlier of: (i) the third anniversary of the
Company’s initial public offering, or (ii) such time as Rule 144 promulgated under the Securities Act (“Rule 144”) or another similar exemption under Securities Act is available for the sale of all of such holder’s Shares
during a three-month period without registration and without other restrictions other than those set forth in paragraphs (f) and (g) of Rule 144. 
 3.2 Recapitalizations, Exchanges, etc. The provisions of this Agreement shall apply to the full extent set forth herein with respect to any shares of capital stock of the Company now or hereafter
held by the 







 
Purchaser, including any such shares (a) converted, exchanged or substituted in any recapitalization or other capital reorganization by the Company, or (b) issued in connection with any
stock dividends, splits, reverse splits, combinations, recapitalizations and the like occurring after the date hereof. The Company shall use its best efforts to cause any successor or assign (whether by sale, merger or otherwise) to enter into a new
investor rights agreement with the holders of Registrable Securities on terms substantially the same as this Agreement as a condition of any such transaction. 
 3.3 Notices. All notices, requests, consents and other communications hereunder shall be in writing and shall be personally delivered or delivered by overnight courier or mailed by first-class
registered or certified mail, postage prepaid, return receipt requested, or by facsimile transmission. Every notice hereunder shall be deemed to have been duly given or served on the date on which personally delivered, with receipt acknowledged,
upon transmission by facsimile and confirmed facsimile receipt. 
 (a) If to a Series A Preferred Stockholder, at such
stockholder’s address as set forth on Schedule I to this Agreement, or at such other address as may have been furnished to the Company by it in writing. 
 (b) If to a Series B Preferred Stockholder, at such stockholder’s address as set forth on Schedule II to this Agreement, or at such other address as may have been furnished to the Company by it in
writing. 
 (c) If to the Company at: 
 Cancer Genetics, Inc. 
 201 Route 17 North, 2nd Floor 

Rutherford, New Jersey 07070 
 Attention: President 
 with a copy to: 

Lavelle & Finn, LLP 
 29 British American Boulevard 
 Latham, New York 12110 

Attn: Keith M. Goldstein, Esq. 
 3.4 Amendments and Waiver. Unless otherwise specifically stated herein, any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or
in a particular instance and either retroactively or prospectively), with the written consent of the Company, and the holders of at least a majority of the Series A Preferred Stock and Series B Preferred Stock voting together as a single class
(including shares of common stock of the Company issued upon conversion of shares of Series A Preferred Stock and Series B Preferred Stock), which amendment or waiver, as the case may be, shall be binding on all of the Parties and shall be binding
on all holders of Series A Preferred Stock and Series B Preferred Stock, if, and to the extent that, such amendment or waiver treats all purchasers of Series A Preferred Stock and Series B Preferred Stock in the same manner. No waivers of or
exceptions to any term, condition or provision of this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision. 

3.5 Entire Agreement. This Agreement embodies the entire agreement and understanding between the Parties and supersedes all prior
agreements and understandings relating to the subject matter hereof. 
 3.6 Severability. The invalidity or
unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provisions of this Agreement. 
 3.7 Governing Law. This Agreement shall be construed and enforced in accordance with the 







 
laws of the State of Delaware without regard to conflicts of law principles. 
 3.8 Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall be binding upon, and inure to the benefit of, the respective representatives,
successors and assigns of the Parties. 
 3.9 Counterparts. This Agreement may be executed in counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 [SIGNATURE PAGE TO
FOLLOW] 







 IN WITNESS WHEREOF, each Party has executed, or caused to be executed by a duly
authorized individual, this Agreement as of the date first set forth above. 
  

			
		 	COMPANY
		
		 	CANCER GENETICS, INC
		
	By:	 	  

		 	Name: 
		 	Title: 
		
		 	SERIES A PREFERRED STOCKHOLDER
		
		 	If an individual:
		
		 	  

		 	[Signature]
		
		 	  

		 	[Print name]
		
		 	If an entity, insert name of entity:
		
		 	  

		
	By:	 	  

		 	Name:
		 	Title:
		
		 	SERIES B PREFERRED STOCKHOLDER
		
		 	If an individual:
		
		 	  

		 	[Signature]
		
		 	  

		 	[Print name]
		
		 	If an entity, insert name of entity:
		
		 	  

		
	By:	 	  

		 	Name:
		 	Title:








 SCHEDULE I 
 Schedule of Series A Preferred Stockholders 
  

					
	If an individual is the Series A Preferred	  		 	
	Stockholder, insert name:	  	  
	 	
			
	If an individual is the Series A Preferred	  		 	
	Stockholder, insert address:	  		 	
		  	  
	 	
			
		  	  
	 	
			
	If an entity is the Series A Preferred	  		 	
	Stockholder, insert name:	  	  
	 	
			
	If an entity is the Series A Preferred	  		 	
	Stockholder, insert address:	  	  
	 	
			
		  	  
	 	
			
		  	  
	 	








 SCHEDULE II 
 Schedule of Series B Preferred Stockholders 
  

					
	If an individual is the Series B Preferred	  		 	
	Stockholder, insert name:	  	  
	 	
			
	If an individual is the Series B Preferred	  		 	
	Stockholder, insert address:	  		 	
		  	  
	 	
			
		  	  
	 	
			
	If an entity is the Series B Preferred	  		 	
	Stockholder, insert name:	  	  
	 	
			
	If an entity is the Series B Preferred	  		 	
	Stockholder, insert address: